GURUFOCUS.COM » STOCK LIST » Financial Services » Diversified Financial Services » Petra Acquisition Inc (NAS:PAICW) » Definitions » Common Stock

PAICW (Petra Acquisition) Common Stock : $73.51 Mil (As of Sep. 2021)


View and export this data going back to 2020. Start your Free Trial

What is Petra Acquisition Common Stock?

Petra Acquisition's quarterly common stock stayed the same from Mar. 2021 ($73.51 Mil) to Jun. 2021 ($73.51 Mil) and stayed the same from Jun. 2021 ($73.51 Mil) to Sep. 2021 ($73.51 Mil).

Petra Acquisition's annual common stock stayed the same from . 20 ($0.00 Mil) to Dec. 2019 ($0.00 Mil) but then increased from Dec. 2019 ($0.00 Mil) to Dec. 2020 ($73.51 Mil).

Petra Acquisition Common Stock Historical Data

The historical data trend for Petra Acquisition's Common Stock can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Petra Acquisition Common Stock Chart

Petra Acquisition Annual Data
Trend Dec19 Dec20
Common Stock
- 73.51

Petra Acquisition Semi-Annual Data
Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21
Common Stock Get a 7-Day Free Trial - 73.51 73.51 73.51 73.51

Petra Acquisition Common Stock Calculation

Common stock is listed on the Balance Sheet at the par value of the total shares outstanding of a company.

The par value of common stocks is meaningless. It is usually set at an absurdly low number.

Petra Acquisition Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Financial Services » Diversified Financial Services » Petra Acquisition Inc (NAS:PAICW) » Definitions » Common Stock
Comparable Companies
Traded in Other Exchanges
N/A
Address
5 West 21st Street, New York, NY, USA, 10010
Website
Petra Acquisition Inc is a blank check company.

Petra Acquisition Headlines

From GuruFocus

Petra Acquisition, Inc. Announces Special Meeting of Stockholders to Approve Business Combination with Revelation Biosciences, Inc.

By GuruFocusNews GuruFocusNews • 12-16-2021

Petra Acquisition Inc. Announces Closing of $70 Million Initial Public Offering

By GlobeNewswire GlobeNewswire • 10-13-2020

Petra Acquisition Inc. Announces Pricing of $70 Million Initial Public Offering

By Marketwired Marketwired • 10-08-2020

PETRA ACQUISITION, INC. ANNOUNCES SECURITIES TO COMMENCE SEPARATE TRADING

By Marketwired Marketwired • 11-10-2020

Revelation Biosciences Inc. Engages Partnering Advisor, MedWorld Advisors, to Optimize Value of the Company's Diagnostic Tool, REVID�

By Marketwired Marketwired • 11-01-2021

Revelation Biosciences Inc. Engages Destum Partners Inc. to Identify Strategic Partners for REVTx-99 (Ex-US) and REVTx-200 (Worldwide)

By Marketwired Marketwired • 10-25-2021

Revelation Biosciences Inc. Announces Initiation of a Phase 2b Study to Assess Efficacy of Intranasal REVTx-99 for The Prevention of H3N2 Influenza

By GuruFocusNews GuruFocusNews • 12-01-2021

Revelation Biosciences Inc. Appoints Joseph A. Bellanti, M.D. to Scientific Advisory Board

By GuruFocusNews GuruFocusNews • 12-06-2021

Revelation Biosciences Inc. Announces Creation and Appointments to Scientific Advisory Board

By GuruFocusNews GuruFocusNews • 11-29-2021

Revelation Biosciences Inc. Receives Approval to Initiate Phase 2b Viral Challenge Study of REVTx 99, an Experimental Prophylactic Treatment for the Prevention of Respiratory Viral Infections

By Marketwired Marketwired • 09-28-2021